An observational study in Early Esophageal Squamous Neoplasia, sponsored by Shandong University. Status unknown at 1 site in China. Open to participants aged 40 Years to 74 Years. Per ClinicalTrials.gov, last updated 2016-08-01.
Sponsored by Shandong University · Observational
The aims of the present study：
Detection and differentiation of esophageal squamous neoplasia (ESN) are of value in improving patient outcomes.Optical enhancement technology can serves in the diagnosis of GI neoplasia. However, its performance in ESN has not yet been reported.The aims of the present study is:
9,359 studies on the registry are indexed under Neoplasms; 2,486 are open to participants now.
This study's planned enrollment of 360 is above the median of 205 across 1,680 observational studies indexed under Neoplasms.
Browse Neoplasms studies →Shandong University is the lead sponsor of 284 studies on the registry; 59 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Consecutive patients screened that fulfill the eligibility criteria at Qilu Hospital, Shandong University will be enrolled into the study.
Patients with high-risk factors for esophageal squamous cell carcinoma who meet any of follows：
Exclusion Criteria:
After routine examination by white-light endoscopy,the imaging mode will be switched to optical enhancement.Suspicious area will be recorded in detail. Then all enrolled patients will have their esophagus sprayed with iodine solution. Suspicious area will be also recorded in detail.After that biopsy specimens will be obtained respectively by forceps from each suspicious lesion recorded for histologic diagnosis.
The detection rate of early esophageal squamous neoplasia by optical enhancement technology.
The detection rate of early esophageal squamous neoplasia by using optical enhancement and Lugol chromoendoscopy.
Time frame: 12 months
The diagnostic accuracy of optical enhancement technology on early esophageal squamous neoplasia.
Patients will be prospectively recruited to evaluate the diagnostic sensitivity, specificity and accuracy of early esophageal squamous neoplasia by using optical enhancement and Lugol chromoendoscopy.
Time frame: 12 months
The different rate of adverse events between optical enhancement and Lugol chromoendoscopy.
Time frame: 12 months
The observation time of optical enhancement and Lugol chromoendoscopy.
Time frame: 12 months
This study is status unknown, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shandong University